{
    "paper_id": "PMC7162744",
    "metadata": {
        "title": "Cannabis et neurod\u00e9veloppement\u2606",
        "authors": [
            {
                "first": "M.-O.",
                "middle": [],
                "last": "Krebs",
                "suffix": "",
                "email": "mo.krebs@ghu-paris.fr",
                "affiliation": {}
            },
            {
                "first": "F.",
                "middle": [],
                "last": "Demars",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "A.",
                "middle": [],
                "last": "Frajerman",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "O.",
                "middle": [],
                "last": "Kebir",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "T.",
                "middle": [],
                "last": "Jay",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Le d\u00e9veloppement c\u00e9r\u00e9bral est un ph\u00e9nom\u00e8ne complexe, qui d\u00e9finit la sp\u00e9cialisation spatio-temporelle de r\u00e9gions c\u00e9r\u00e9brales et sous-tend leurs relations fonctionnelles actuelles et futures. Il s\u2019\u00e9tend de la conception jusqu\u2019\u00e0 la maturit\u00e9, non pas de fa\u00e7on lin\u00e9aire mais en fonction de phases \u00ab critiques \u00bb, qui d\u00e9finissent des p\u00e9riodes pendant lesquelles certaines \u00e9tapes doivent se produire, ne pouvant \u00eatre compens\u00e9es ult\u00e9rieurement. La p\u00e9riode p\u00e9rinatale et l\u2019adolescence sont des p\u00e9riodes critiques, au m\u00eame titre que les phases du d\u00e9veloppement pr\u00e9coce : perturber des processus devant avoir lieu durant cette p\u00e9riode peut avoir des cons\u00e9quences \u00e0 long terme. L\u2019exemple prototypique est l\u2019amblyopie, o\u00f9 l\u2019absence de stimulation visuelle avant 5 ans aboutit \u00e0 une c\u00e9cit\u00e9 corticale, m\u00eame quand l\u2019obstacle est lev\u00e9, du fait de la non-maturation des circuits corticaux pendant la p\u00e9riode critique [1].",
            "cite_spans": [
                {
                    "start": 897,
                    "end": 900,
                    "mention": "[1]",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Le d\u00e9veloppement c\u00e9r\u00e9bral un processus non lin\u00e9aire qui s\u2019\u00e9tend en post natal ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Les p\u00e9riodes critiques sont des p\u00e9riodes o\u00f9 l\u2019environnement joue un r\u00f4le crucial dans la modulation du bon d\u00e9veloppement des circuits neuronaux. Ce sont aussi des fen\u00eatres de vuln\u00e9rabilit\u00e9 accrue. Toute d\u00e9viation dans la s\u00e9quence ordonn\u00e9e des \u00e9v\u00e9nements entra\u00eene des cons\u00e9quences fonctionnelles r\u00e9v\u00e9l\u00e9es plus tard dans la vie : retard, d\u00e9crochage ou acc\u00e9l\u00e9ration de maturation, perturbations de l\u2019\u00e9quilibre des aff\u00e9rences excitateur/inhibiteur ou de la synchronisation des \u00e9v\u00e9nements critiques peuvent d\u00e9coupler la progression du d\u00e9veloppement des r\u00e9gions et circuits c\u00e9r\u00e9braux et provoquer des troubles cognitifs ou mentaux durables.",
            "cite_spans": [],
            "section": "Le d\u00e9veloppement c\u00e9r\u00e9bral un processus non lin\u00e9aire qui s\u2019\u00e9tend en post natal ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Durant la p\u00e9riode p\u00e9rinatale, qui inclut la p\u00e9riode d\u2019allaitement, divers processus de d\u00e9veloppement surviennent comme la dendritogen\u00e8se ou la formation synaptique, la r\u00e9partition des canaux ioniques excitateurs/inhibiteurs, faisant de cette p\u00e9riode une fen\u00eatre temporelle de forte sensibilit\u00e9 aux influences environnementales.",
            "cite_spans": [],
            "section": "Le d\u00e9veloppement c\u00e9r\u00e9bral un processus non lin\u00e9aire qui s\u2019\u00e9tend en post natal ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Le delta-9-t\u00e9trahydrocanabinol (THC), principal composant psychoactif pr\u00e9sent dans le cannabis, est hautement lipophile et diffuse dans le cerveau, le placenta et le lait maternel. Du fait de la longue demi-vie des cannabino\u00efdes et de la rapidit\u00e9 du neurod\u00e9veloppement au cours de cette p\u00e9riode, m\u00eame des niveaux d\u2019exposition apparemment faibles peuvent avoir des cons\u00e9quences importantes sur le d\u00e9veloppement c\u00e9r\u00e9bral [2].",
            "cite_spans": [
                {
                    "start": 419,
                    "end": 422,
                    "mention": "[2]",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Le d\u00e9veloppement c\u00e9r\u00e9bral un processus non lin\u00e9aire qui s\u2019\u00e9tend en post natal ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Durant l\u2019adolescence, les r\u00e9gions temporales et surtout les circuits du cortex pr\u00e9frontal subissent d\u2019importants remaniements (my\u00e9linisation, \u00e9limination synaptique, r\u00e9duction de la substance grise[3]. Cette p\u00e9riode s\u2019\u00e9tend de la pubert\u00e9 (10\u201312 ans) jusqu\u2019\u00e0 25 voire 30 ans pour la my\u00e9linisation des derni\u00e8res r\u00e9gions. Ces processus ne sont ni lin\u00e9aires, ni homog\u00e8nes, engendrant \u00ab physiologiquement \u00bb des d\u00e9s\u00e9quilibres dans la r\u00e9gulation du comportement : la maturation des circuits sous corticaux est plus pr\u00e9coce que celle des r\u00e9gions impliqu\u00e9es dans la planification et la capacit\u00e9 d\u2019inhibition (r\u00e9gions pr\u00e9frontales) ce qui entra\u00eene une hypersensibilit\u00e9 \u00e9motionnelle (sensibilit\u00e9 \u00e0 la r\u00e9compense). Ce d\u00e9s\u00e9quilibre fonctionnel cortico-sous cortical peut expliquer les changements comportementaux de l\u2019adolescence, en particulier l\u2019impulsivit\u00e9, l\u2019absence de planification, la recherche de nouvelles exp\u00e9riences et inciter \u00e0 l\u2019exp\u00e9rimentation de substances, notamment la prise de cannabis.",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 200,
                    "mention": "[3]",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Le d\u00e9veloppement c\u00e9r\u00e9bral un processus non lin\u00e9aire qui s\u2019\u00e9tend en post natal ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Parmi les nombreux signaux chimiques permettant la transmission synaptique dans le cerveau, le syst\u00e8me cannabino\u00efde endog\u00e8ne est largement distribu\u00e9 et comprend des r\u00e9cepteurs aux cannabino\u00efdes (CB1R et CB2R) activ\u00e9s par des substances endog\u00e8nes, les endocannabino\u00efdes (eCB). Ce syst\u00e8me remplit des fonctions cl\u00e9s pendant le d\u00e9veloppement c\u00e9r\u00e9bral notamment par l\u2019activation des r\u00e9cepteurs CB1R dont l\u2019expression dans les diverses zones c\u00e9r\u00e9brales est pr\u00e9cis\u00e9ment contr\u00f4l\u00e9e au cours du temps d\u00e8s le d\u00e9veloppement pr\u00e9coce [2], [4]. Il est \u00e9galement impliqu\u00e9 dans la prolif\u00e9ration et la diff\u00e9renciation des prog\u00e9niteurs neuraux, dans la migration neuronale, dans la guidance des axones et dans la mise en place des connexions synaptiques entre r\u00e9gions c\u00e9r\u00e9brales [2], [5], [6]. Les eCB sont synth\u00e9tis\u00e9s \u00ab \u00e0 la demande \u00bb au niveau postsynaptique \u00e0 partir de pr\u00e9curseurs phospholipidiques de la membrane et agissent sur les r\u00e9cepteurs CB1R du neurone pr\u00e9synaptique ce qui r\u00e9gule la lib\u00e9ration de neurotransmetteurs [7]. Ce syst\u00e8me module l\u2019efficacit\u00e9 et la plasticit\u00e9 synaptiques. Il joue donc un r\u00f4le majeur dans le fonctionnement et dans les processus neurod\u00e9veloppementaux de mise en place et de maturation des connexions synaptiques [8], [9].",
            "cite_spans": [
                {
                    "start": 521,
                    "end": 524,
                    "mention": "[2]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 526,
                    "end": 529,
                    "mention": "[4]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 761,
                    "end": 764,
                    "mention": "[2]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 766,
                    "end": 769,
                    "mention": "[5]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 771,
                    "end": 774,
                    "mention": "[6]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1011,
                    "end": 1014,
                    "mention": "[7]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1233,
                    "end": 1236,
                    "mention": "[8]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 1238,
                    "end": 1241,
                    "mention": "[9]",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Le syst\u00e8me cannabino\u00efde endog\u00e8ne est impliqu\u00e9 dans le d\u00e9veloppement ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Les pics d\u2019expression des CB1R surviennent lorsque la connectivit\u00e9 synaptique est \u00e9tablie par les cellules pyramidales corticales et interneurones GABAergiques. Les CB1R influencent la prolif\u00e9ration des prog\u00e9niteurs neuronaux, la croissance axonale et l\u2019orientation de l\u2019axone. Chez l\u2019homme et les rongeurs, ce pic d\u2019expression CB1R est \u00e9troitement corr\u00e9l\u00e9 avec les niveaux de l\u2019eCB 2-Arachidonylglyc\u00e9rol (2-AG) [2]. Le r\u00f4le de CB1R dans le neurod\u00e9veloppement pr\u00e9coce est r\u00e9v\u00e9l\u00e9 chez des souris g\u00e9n\u00e9tiquement modifi\u00e9es d\u00e9pourvues de ces r\u00e9cepteurs. Les souris d\u00e9pourvues de CB1R sont pr\u00e9dispos\u00e9es \u00e0 des comportements de type d\u00e9pressif et pr\u00e9sentent des caract\u00e9ristiques du d\u00e9veloppement c\u00e9r\u00e9bral aberrant, telles que des niveaux diminu\u00e9s de facteurs neurotrophiques, des alt\u00e9rations de l\u2019axe hypothalamo--hypophyse-surr\u00e9nalien (HPS) et des cytokines pro-inflammatoires.",
            "cite_spans": [
                {
                    "start": 412,
                    "end": 415,
                    "mention": "[2]",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Le syst\u00e8me cannabino\u00efde endog\u00e8ne est impliqu\u00e9 dans le d\u00e9veloppement ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "\u00c0 l\u2019adolescence, le syst\u00e8me endocannabinoide subit des modifications parmi lesquelles des modifications des niveaux d\u2019endocannabino\u00efdes et de CB1R variable selon les r\u00e9gions c\u00e9r\u00e9brales : l\u2019expression de CB1R augmente dans les zones cl\u00e9s impliqu\u00e9es dans la maturation (cortex frontal, le striatum et l\u2019hippocampe, le noyau Accumbens\u2026) [10], [11]. Ces zones du cerveau jouent un r\u00f4le dans le traitement de l\u2019information \u00e9motionnelle, l\u2019apprentissage et la m\u00e9moire et sont impliqu\u00e9es dans de nombreux troubles neuropsychiatriques [12].",
            "cite_spans": [
                {
                    "start": 334,
                    "end": 338,
                    "mention": "[10]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 340,
                    "end": 344,
                    "mention": "[11]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 527,
                    "end": 531,
                    "mention": "[12]",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Le syst\u00e8me cannabino\u00efde endog\u00e8ne est impliqu\u00e9 dans le d\u00e9veloppement ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Parmi les nombreux composants du cannabis, le THC est le principal composant psychoactif. Il se lie au CB1R et agit comme un agoniste partiel. Sa concentration varie grandement dans les diff\u00e9rentes souches de cannabis, allant de 6\u201314 % \u00e0 20 % dans certaines souches, de plus en plus utilis\u00e9es. \u00c0 l\u2019inverse, le cannabidiol (CBD) est d\u00e9pourvu d\u2019activit\u00e9 sur les r\u00e9cepteurs cannabino\u00efdes, mais le CBD att\u00e9nuerait certains effets ind\u00e9sirables (anxi\u00e9t\u00e9, attaques de panique, sympt\u00f4mes psychotiques, troubles cognitifs). Les cannabino\u00efdes de synth\u00e8se sont des agonistes complets et puissants des CB1R, avec des effets encore plus marqu\u00e9s que le THC. Le THC peut perturber le fonctionnement du syst\u00e8me endocannabino\u00efde, soit directement en tant qu\u2019agoniste partiel des r\u00e9cepteurs cannabino\u00efde de type 1 CB1R, soit par le biais de processus de r\u00e9gulation indirect inhibant la signalisation CB1R [13] ou encore via son activit\u00e9 de r\u00e9gulation d\u2019autres syst\u00e8mes de neurotransmission, notamment dopaminergique, glutamatergique NMDA ou GABAergiques [11], [14].",
            "cite_spans": [
                {
                    "start": 887,
                    "end": 891,
                    "mention": "[13]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 1036,
                    "end": 1040,
                    "mention": "[11]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1042,
                    "end": 1046,
                    "mention": "[14]",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Le syst\u00e8me cannabino\u00efde endog\u00e8ne est impliqu\u00e9 dans le d\u00e9veloppement ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Les exp\u00e9riences sur l\u2019animal pr\u00e9sentent un grand int\u00e9r\u00eat car elles \u00e9vitent des facteurs confusionnels potentiels comme la consommation associ\u00e9e (alcool, tabac, autres substances). L\u2019exposition au THC in utero ou en p\u00e9rinatal chez les rongeurs a \u00e9t\u00e9 directement associ\u00e9e \u00e0 de nombreux d\u00e9ficits cognitifs et \u00e9motionnels \u00e0 long terme [15], [16]. Les perturbations structurelles et fonctionnelles des syst\u00e8mes dopaminergique et GABAergique observ\u00e9es [17], [18], [19] sont coh\u00e9rentes avec celles observ\u00e9es chez l\u2019homme, montrant que l\u2019exposition au cannabis in utero entra\u00eene une expression anormale des r\u00e9cepteurs dopaminergique D2 dans l\u2019amygdale [4]. Des alt\u00e9rations de l\u2019excitabilit\u00e9 des neurones et de la plasticit\u00e9 synaptique au niveau cortex pr\u00e9frontal et de l\u2019hippocampe ont aussi \u00e9t\u00e9 rapport\u00e9es [20]. L\u2019exposition au cannabis durant la gestation et p\u00e9riode p\u00e9rinatale perturbe le r\u00f4le physiologique de la signalisation eCB dans la programmation du d\u00e9veloppement et alt\u00e8re la synaptogen\u00e8se et le bon d\u00e9veloppement des circuits neuronaux (Tableau 1\n).",
            "cite_spans": [
                {
                    "start": 331,
                    "end": 335,
                    "mention": "[15]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 337,
                    "end": 341,
                    "mention": "[16]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 446,
                    "end": 450,
                    "mention": "[17]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 452,
                    "end": 456,
                    "mention": "[18]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 458,
                    "end": 462,
                    "mention": "[19]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 644,
                    "end": 647,
                    "mention": "[4]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 799,
                    "end": 803,
                    "mention": "[20]",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Exposition au cours du d\u00e9veloppement pr\u00e9coce ::: Introduction",
            "ref_spans": [
                {
                    "start": 1041,
                    "end": 1050,
                    "mention": "Tableau 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Chez l\u2019homme, une revue incluant 3 \u00e9tudes de cohortes prospectives a montr\u00e9 que les enfants expos\u00e9s in utero au cannabis pr\u00e9sentent plus d\u2019impulsivit\u00e9 et d\u2019hyperactivit\u00e9 \u00e0 6 ans et apr\u00e8s 9 ans, des alt\u00e9rations du raisonnement abstrait et du fonctionnement visuo-perceptuel [21]. Dans une \u00e9tude de cohorte de 4361 enfants, la consommation de cannabis apr\u00e8s la connaissance de la grossesse \u00e9tait associ\u00e9e \u00e0 une pr\u00e9disposition accrue \u00e0 la psychose chez les enfants \u00e9valu\u00e9s \u00e0 l\u2019\u00e2ge de 10 ans par questionnaire [22]. L\u2019exposition pr\u00e9natale au cannabis a aussi des effets persistants jusqu\u2019\u00e0 l\u2019\u00e2ge adulte sur la m\u00e9moire de travail et les fonctions ex\u00e9cutives [15], [23] et elle augmenterait la vuln\u00e9rabilit\u00e9 aux addictions [24]. De plus, des \u00e9tudes d\u2019imagerie par r\u00e9sonance magn\u00e9tique fonctionnelle (IRMf) ont montr\u00e9 que l\u2019exposition pr\u00e9natale est associ\u00e9e \u00e0 une alt\u00e9ration du fonctionnement de plusieurs zones du cerveau chez le jeune adulte lors de tests impliquant la m\u00e9moire de travail visuospatiale et l\u2019inhibition [15], [25].",
            "cite_spans": [
                {
                    "start": 273,
                    "end": 277,
                    "mention": "[21]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 506,
                    "end": 510,
                    "mention": "[22]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 653,
                    "end": 657,
                    "mention": "[15]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 659,
                    "end": 663,
                    "mention": "[23]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 717,
                    "end": 721,
                    "mention": "[24]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 1014,
                    "end": 1018,
                    "mention": "[15]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1020,
                    "end": 1024,
                    "mention": "[25]",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Exposition au cours du d\u00e9veloppement pr\u00e9coce ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Ces travaux confirment les risques associ\u00e9s \u00e0 l\u2019exposition au cours du d\u00e9veloppement pr\u00e9coce au cannabis. Comme cela a d\u00e9j\u00e0 \u00e9t\u00e9 d\u00e9crit avec certains perturbateurs endocriniens [26], cette exposition au cannabis au cours du d\u00e9veloppement est consid\u00e9r\u00e9e par certains comme une premi\u00e8re atteinte, augmentant la vuln\u00e9rabilit\u00e9 ult\u00e9rieure aux stresseurs environnementaux, qui r\u00e9v\u00e8lent secondairement ces alt\u00e9rations pr\u00e9coces par l\u2019expression de troubles psychiatriques (d\u00e9pression, psychose) et/ou cognitifs [2].",
            "cite_spans": [
                {
                    "start": 176,
                    "end": 180,
                    "mention": "[26]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 502,
                    "end": 505,
                    "mention": "[2]",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Exposition au cours du d\u00e9veloppement pr\u00e9coce ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Les mod\u00e8les animaux sont utiles pour \u00e9tudier les bases neurobiologiques des effets \u00e0 long terme de l\u2019exposition au cannabis pendant l\u2019adolescence sur le comportement \u00e0 l\u2019\u00e2ge adulte, \u00e0 distance de l\u2019exposition. Alors que des rongeurs expos\u00e9s \u00e0 l\u2019\u00e2ge adulte \u00e0 des agonistes CB1R ou au THC ont peu de d\u00e9ficits qui persistent \u00e0 distance, l\u2019exposition \u00e0 l\u2019adolescence entra\u00eene des troubles de la m\u00e9moire \u00e0 court terme, de la m\u00e9moire de travail spatiale et des interactions sociales \u00e0 l\u2019\u00e2ge adulte [11], [27]. Ces anomalies s\u2019accompagnent d\u2019une diminution des prot\u00e9ines impliqu\u00e9es dans la plasticit\u00e9 synaptique et de l\u2019expression de CB1R, ainsi que d\u2019une perturbation de la maturation des syst\u00e8mes dopaminergiques, glutamatergiques, s\u00e9rotoninergique et GABAergique dans l\u2019hippocampe et le cortex pr\u00e9frontal [15], [28] et m\u00eame de la morphologie dendritique au niveau pr\u00e9frontal [28]. Le THC \u00e0 l\u2019adolescence alt\u00e8re aussi l\u2019expression de r\u00e9seaux de g\u00e8nes impliqu\u00e9s dans la morphogen\u00e8se cellulaire, le d\u00e9veloppement dendritique et l\u2019organisation du cytosquelette au niveau pr\u00e9frontal [29].",
            "cite_spans": [
                {
                    "start": 492,
                    "end": 496,
                    "mention": "[11]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 498,
                    "end": 502,
                    "mention": "[27]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 801,
                    "end": 805,
                    "mention": "[15]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 807,
                    "end": 811,
                    "mention": "[28]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 871,
                    "end": 875,
                    "mention": "[28]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 1074,
                    "end": 1078,
                    "mention": "[29]",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Cannabis et adolescence ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Cependant, il existe des diff\u00e9rences interindividuelles dans la r\u00e9ponse \u00e0 une exposition au THC. \u00c0 titre d\u2019exemple, une pr\u00e9disposition g\u00e9n\u00e9tique, restreinte aux astrocytes, a r\u00e9cemment \u00e9t\u00e9 impliqu\u00e9e dans la s\u00e9v\u00e9rit\u00e9 des alt\u00e9rations cognitives d\u2019animaux adultes ayant \u00e9t\u00e9 expos\u00e9s au THC \u00e0 l\u2019adolescence, r\u00e9v\u00e9lant le r\u00f4le de certaines voies de signalisations dans ce ph\u00e9nom\u00e8ne de r\u00e9silience/vuln\u00e9rabilit\u00e9 [30] (Tableau 2\n).",
            "cite_spans": [
                {
                    "start": 403,
                    "end": 407,
                    "mention": "[30]",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Cannabis et adolescence ::: Introduction",
            "ref_spans": [
                {
                    "start": 409,
                    "end": 418,
                    "mention": "Tableau 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "La majorit\u00e9 des \u00e9tudes \u00e9valuant les effets chroniques du cannabis montre que les utilisateurs r\u00e9guliers pr\u00e9sentent des performances cognitives alt\u00e9r\u00e9es par rapport \u00e0 des non-consommateurs dans un large \u00e9ventail de domaines cognitifs [31]. L\u2019apprentissage verbal et la m\u00e9moire, l\u2019attention et la fonction psychomotrice sont syst\u00e9matiquement alt\u00e9r\u00e9s par une exposition aigu\u00eb et chronique au cannabis et ces effets sont plus marqu\u00e9s pour une consommation pr\u00e9coce [32]. Dans la cohorte de naissance de Dunedin, la poursuite de la consommation de cannabis est associ\u00e9e \u00e0 un d\u00e9clin du fonctionnement g\u00e9n\u00e9ral (en moyenne 10 points de QI) et particuli\u00e8rement chez les consommateurs ayant d\u00e9but\u00e9 \u00e0 l\u2019adolescence [33]. Le d\u00e9clin cognitif est moindre chez les personnes ayant d\u00e9but\u00e9 leur consommation \u00e0 l\u2019adolescence puis cess\u00e9 \u00e0 l\u2019\u00e2ge adulte, mais ce d\u00e9clin reste n\u00e9anmoins significatif malgr\u00e9 l\u2019arr\u00eat, par rapport \u00e0 des non-consommateurs. Cependant, cet effet est influenc\u00e9 par d\u2019autres facteurs, notamment la dur\u00e9e : dans un \u00e9chantillon limit\u00e9 de jumeaux, il n\u2019a pas \u00e9t\u00e9 retrouv\u00e9 d\u2019association entre consommation de cannabis \u00e0 court terme \u00e0 l\u2019adolescence et d\u00e9clin durable du QI ou des fonctions ex\u00e9cutives [34].",
            "cite_spans": [
                {
                    "start": 233,
                    "end": 237,
                    "mention": "[31]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 460,
                    "end": 464,
                    "mention": "[32]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 703,
                    "end": 707,
                    "mention": "[33]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1199,
                    "end": 1203,
                    "mention": "[34]",
                    "ref_id": "BIBREF34"
                }
            ],
            "section": "Cannabis et adolescence ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Les \u00e9tudes d\u2019imagerie c\u00e9r\u00e9brale chez l\u2019homme montrent que l\u2019exposition chronique au cannabis induit une r\u00e9duction de volume de mati\u00e8re grise dans les r\u00e9gions c\u00e9r\u00e9brales pr\u00e9sentant une concentration \u00e9lev\u00e9e de CB1R, c\u2019est-\u00e0-dire, dans l\u2019hippocampe, le cortex pr\u00e9frontal, l\u2019amygdale et le cervelet [35], [36], [37]. Plusieurs \u00e9tudes font \u00e9tat d\u2019une alt\u00e9ration de la substance blanche dans de nombreuses zones du cerveau (tractus pr\u00e9frontal, limbique, pari\u00e9tal et c\u00e9r\u00e9belleux) chez les consommateurs de cannabis adolescents. Les modifications sont plus marqu\u00e9es pour une concentration \u00e9lev\u00e9e en THC et une consommation pr\u00e9coce, ce qui souligne l\u2019interaction entre THC et d\u00e9veloppement c\u00e9r\u00e9bral [38]. En outre, chez les adolescents, la consommation de cannabis chronique alt\u00e8re l\u2019activation c\u00e9r\u00e9brale dans des t\u00e2ches impliquant le fonctionnement ex\u00e9cutif, l\u2019attention, la m\u00e9moire de travail, l\u2019apprentissage verbal, le traitement affectif et le traitement des r\u00e9compenses. Le profil d\u2019activation est diff\u00e9rent entre consommateurs adultes et adolescents chez qui les alt\u00e9rations touchent le gyrus pari\u00e9tal inf\u00e9rieur et le putamen [10]. \u00c0 nouveau, l\u2019utilisation plus pr\u00e9coce et plus intense de cannabis est associ\u00e9e \u00e0 des alt\u00e9rations plus marqu\u00e9es de la structure et de l\u2019activation des r\u00e9gions c\u00e9r\u00e9brales mises en jeu lors de t\u00e2ches cognitives n\u00e9cessitant une prise de d\u00e9cision et une inhibition, tel que le cervelet [38], [39]. Enfin, une m\u00e9ta-analyse r\u00e9cente sugg\u00e8re qu\u2019une activation anormale des r\u00e9seaux central ex\u00e9cutif et du mode par d\u00e9faut persiste chez des adolescents consommateurs de cannabis apr\u00e8s 25 jours d\u2019abstinence [40].",
            "cite_spans": [
                {
                    "start": 295,
                    "end": 299,
                    "mention": "[35]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 301,
                    "end": 305,
                    "mention": "[36]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 307,
                    "end": 311,
                    "mention": "[37]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 690,
                    "end": 694,
                    "mention": "[38]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1124,
                    "end": 1128,
                    "mention": "[10]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1411,
                    "end": 1415,
                    "mention": "[38]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1417,
                    "end": 1421,
                    "mention": "[39]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 1625,
                    "end": 1629,
                    "mention": "[40]",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "Cannabis et adolescence ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Il est aujourd\u2019hui bien d\u00e9montr\u00e9 que les troubles psychiatriques, ceux de l\u2019enfant comme ceux de l\u2019adulte, sont favoris\u00e9s par une alt\u00e9ration du neurod\u00e9veloppement et sont en lien avec la maturation c\u00e9r\u00e9brale. Plus pr\u00e9cis\u00e9ment, les trois-quarts des troubles psychiatriques d\u00e9butent avant l\u2019\u00e2ge de 25 ans, avec un pic entre 12 et 30 ans, refl\u00e9tant la vuln\u00e9rabilit\u00e9 associ\u00e9e \u00e0 cette p\u00e9riode critique de l\u2019adolescence. Notons que la modification de la l\u00e9gislation aux USA a entra\u00een\u00e9 une augmentation de la pr\u00e9valence des troubles de la consommation du cannabis particuli\u00e8rement chez les jeunes de 12\u201317 ans [41].",
            "cite_spans": [
                {
                    "start": 603,
                    "end": 607,
                    "mention": "[41]",
                    "ref_id": "BIBREF41"
                }
            ],
            "section": "Complications psychiatriques ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "L\u2019induction d\u2019un syndrome amotivationnel est tr\u00e8s fr\u00e9quente lors d\u2019une consommation chronique. Il est caract\u00e9ris\u00e9 par l\u2019anh\u00e9donie, le d\u00e9sint\u00e9r\u00eat, le d\u00e9tachement \u00e9motionnel, la perte de l\u2019initiative, l\u2019apragmatisme, la passivit\u00e9, l\u2019apathie, l\u2019appauvrissement intellectuel et le retrait social. Il peut persister quelques semaines apr\u00e8s le sevrage et r\u00e9gresse ensuite spontan\u00e9ment.",
            "cite_spans": [],
            "section": "Complications psychiatriques ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Les premi\u00e8res donn\u00e9es faisant un lien entre consommation de cannabis et schizophr\u00e9nie remontent \u00e0 plus de 30 ans [31]. La premi\u00e8re \u00e9tude prospective a \u00e9t\u00e9 men\u00e9e aupr\u00e8s de jeunes appel\u00e9s de l\u2019arm\u00e9e su\u00e9doise par Andreasson et al., en 1987. Les auteurs pointent que la consommation de cannabis plus de 50 fois \u00e0 ou avant 18 ans (soit approximativement une fois par semaine pendant un an) multiplie par six le risque de schizophr\u00e9nie 15 ans plus tard. En \u00e9largissant l\u2019\u00e9chantillon (plus de 50 000 personnes), la dur\u00e9e du suivi et l\u2019analyse visant \u00e0 traiter tous les facteurs confondant possibles, les auteurs confirment un risque accru de schizophr\u00e9nie apr\u00e8s une exposition au cannabis, m\u00eame apr\u00e8s avoir \u00e9limin\u00e9 une \u00e9ventuelle psychose d\u00e9butante, le r\u00f4le des autres drogues, l\u2019influence d\u2019une vuln\u00e9rabilit\u00e9 familiale\u2026 La consommation pr\u00e9coce de cannabis (15\u201318 ans) multiplie encore plus le risque de d\u00e9velopper des sympt\u00f4mes psychotiques (risque suppl\u00e9mentaire entre 2 \u00e0 4 fois) [35], [42]. Une \u00e9tude de cohorte de naissance sur 50 000 sujets suivis pendant 35 ans retrouve que le risque accru de schizophr\u00e9nie chez les consommateurs fr\u00e9quents de cannabis \u00e0 l\u2019adolescence \u00e9tait de 3,7 par rapport aux non-utilisateurs [43]. Certains auteurs estiment que 8 \u00e0 13 % des patients n\u2019auraient jamais d\u00e9velopp\u00e9 de sympt\u00f4mes schizophr\u00e9niques s\u2019ils n\u2019avaient pas consomm\u00e9 de cannabis [44]. Une m\u00e9ta-revue r\u00e9cente rapporte que la consommation de cannabis est associ\u00e9e \u00e0 un d\u00e9but plus pr\u00e9coce de la psychose, \u00e0 une augmentation du taux de rechute, \u00e0 un plus grand nombre d\u2019hospitalisations et \u00e0 des sympt\u00f4mes positifs prononc\u00e9s chez les patients psychotiques [45]. Elle confirme aussi l\u2019impact de la dose consomm\u00e9e. Par ailleurs, l\u2019association entre la consommation de cannabis et les troubles de l\u2019humeur et d\u2019anxi\u00e9t\u00e9 est d\u00e9montr\u00e9e, en particulier chez les femmes, et d\u00e9pend de l\u2019importance de la consommation de cannabis. N\u00e9anmoins, au-del\u00e0 de ces \u00e9tudes montrant une possible causalit\u00e9, l\u2019association entre troubles psychiatriques et consommation de cannabis pourrait aussi refl\u00e9ter une pr\u00e9disposition partag\u00e9e (pour revue [31]).",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 117,
                    "mention": "[31]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 976,
                    "end": 980,
                    "mention": "[35]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 982,
                    "end": 986,
                    "mention": "[42]",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 1215,
                    "end": 1219,
                    "mention": "[43]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 1372,
                    "end": 1376,
                    "mention": "[44]",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 1645,
                    "end": 1649,
                    "mention": "[45]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 2112,
                    "end": 2116,
                    "mention": "[31]",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Complications psychiatriques ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Le potentiel addictif du cannabis, un temps discut\u00e9, est maintenant bien \u00e9tabli. Le trouble de l\u2019usage de cannabis (abus et d\u00e9pendance) se manifeste \u00e0 travers plusieurs dimensions : l\u2019impact sur les obligations scolaires et professionnelles (fl\u00e9chissement des r\u00e9sultats, absent\u00e9isme, d\u00e9sinvestissement) ; conduites \u00e0 risque et transgressions pouvant donner lieu \u00e0 des poursuites judiciaires ; le changement de l\u2019entourage amical, avec d\u00e9sinvestissement des amiti\u00e9s de longue date et un retrait voire une opposition franche vis-\u00e0-vis de l\u2019autorit\u00e9 parentale et enfin la tol\u00e9rance, entra\u00eenant une moindre sensibilit\u00e9 et augmentation des doses en qu\u00eate de nouveaux effets (ou recherche de produits plus fortement dos\u00e9s). Il existe une utilisation compulsive (un craving) et des efforts infructueux pour diminuer ou contr\u00f4ler sa consommation. On estime qu\u2019un exp\u00e9rimentateur sur 11 d\u00e9veloppera un trouble addictif sur la vie, ce risque \u00e9tant doubl\u00e9 si l\u2019initiation se fait pendant l\u2019adolescence [31]. Dans une \u00e9tude am\u00e9ricaine r\u00e9cente, trois fumeurs de cannabis sur 10 remplissent les crit\u00e8res d\u2019un trouble li\u00e9 \u00e0 l\u2019usage de cannabis selon les crit\u00e8res du DSM-IV et, la pr\u00e9valence du trouble li\u00e9 \u00e0 l\u2019usage de cannabis \u00e9valu\u00e9 sur l\u2019ann\u00e9e derni\u00e8re a doubl\u00e9 chez les adultes am\u00e9ricains depuis 2001 [46].",
            "cite_spans": [
                {
                    "start": 991,
                    "end": 995,
                    "mention": "[31]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 1290,
                    "end": 1294,
                    "mention": "[46]",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "Complications psychiatriques ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "\u00c0 l\u2019inverse, le cannabidiol pourrait avoir des propri\u00e9t\u00e9s \u00ab protectrices \u00bb [47] mais les r\u00e9sultats \u00e0 ce jour restent controvers\u00e9s [48], [49]. En particulier, un essai a sugg\u00e9r\u00e9 l\u2019int\u00e9r\u00eat du CBD pour att\u00e9nuer les troubles psychotiques[50] mais une autre \u00e9tude a obtenu des r\u00e9sultats n\u00e9gatifs [51]. Des \u00e9tudes sont en cours pour \u00e9tudier plus pr\u00e9cis\u00e9ment les effets du CBD. Certains travaux r\u00e9alis\u00e9s chez des mod\u00e8les animaux pour la schizophr\u00e9nie [52], [53] ou expos\u00e9s au THC [54], [55] ont montr\u00e9 que l\u2019injection de CBD pendant l\u2019adolescence peut pr\u00e9venir l\u2019apparition de certaines anomalies neurobiologiques et comportementales \u00e0 court ou long terme telles que l\u2019hyperactivit\u00e9 locomotrice, la baisse des performances mn\u00e9siques, la r\u00e9duction des interactions sociales ou l\u2019augmentation de l\u2019anxi\u00e9t\u00e9 des animaux. Cependant, ces r\u00e9sultats n\u2019ont pas toujours \u00e9t\u00e9 r\u00e9pliqu\u00e9s et il convient de rester prudent car certaines \u00e9tudes ont mis en \u00e9vidence des cons\u00e9quences d\u00e9l\u00e9t\u00e8res telles qu\u2019une aggravation des anomalies dans le groupe mod\u00e8le, voire la diminution des interactions sociales dans le groupe contr\u00f4le expos\u00e9 au CBD [55], [56]\n",
            "cite_spans": [
                {
                    "start": 75,
                    "end": 79,
                    "mention": "[47]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 130,
                    "end": 134,
                    "mention": "[48]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 136,
                    "end": 140,
                    "mention": "[49]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 233,
                    "end": 237,
                    "mention": "[50]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 291,
                    "end": 295,
                    "mention": "[51]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 444,
                    "end": 448,
                    "mention": "[52]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 450,
                    "end": 454,
                    "mention": "[53]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 473,
                    "end": 477,
                    "mention": "[54]",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 479,
                    "end": 483,
                    "mention": "[55]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1116,
                    "end": 1120,
                    "mention": "[55]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1122,
                    "end": 1126,
                    "mention": "[56]",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Complications psychiatriques ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "La consommation de cannabis est susceptible d\u2019entra\u00eener des perturbations durables du d\u00e9veloppement et de la maturation du cerveau, persistant au-del\u00e0 de la p\u00e9riode de consommation, avec des cons\u00e9quences sur le plan cognitif, psychotique et addictif. Plusieurs facteurs modulent le risque de telles complications (comme la dose, la dur\u00e9e, la proportion de THC, et une vuln\u00e9rabilit\u00e9 individuelle) mais l\u2019exposition in utero, en post natal et durant la p\u00e9riode de la maturation c\u00e9r\u00e9brale de l\u2019adolescence et du jeune adulte constitue en soi un facteur de risque majeur. Les donn\u00e9es actuelles incitent \u00e0 poursuivre les travaux de recherche pour affiner l\u2019estimation du risque de complication en cas d\u2019exposition, mais aussi \u00e0 d\u2019ores et d\u00e9j\u00e0 entreprendre une v\u00e9ritable politique de diffusion d\u2019informations objectives aux jeunes, et ce d\u00e8s la fin du primaire, pour pr\u00e9venir et limiter les consommations pr\u00e9coces, dans un contexte o\u00f9 l\u2019on peut craindre une augmentation de la pr\u00e9valence des troubles de la consommation du cannabis chez les jeunes de 12\u201317 ans si le cannabis devient plus accessible.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "Les auteurs d\u00e9clarent ne pas avoir de liens d\u2019int\u00e9r\u00eats.",
            "cite_spans": [],
            "section": "D\u00e9claration de liens d\u2019int\u00e9r\u00eats",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Tableau 1: Cons\u00e9quences de l\u2019exposition p\u00e9rinatale au cannabis chez l\u2019homme et les rongeurs.\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Tableau 2: Cons\u00e9quences de l\u2019exposition \u00e0 l\u2019adolescence au cannabis chez l\u2019homme et les rongeurs.\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Cannabidiol potentiates \u03949-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats",
            "authors": [
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Klein",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Karanges",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Spiro",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Spencer",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Huynh",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Psychopharmacology (Berl)",
            "volume": "218",
            "issn": "",
            "pages": "443-457",
            "other_ids": {
                "DOI": [
                    "10.1007/s00213-011-2342-0"
                ]
            }
        },
        "BIBREF1": {
            "title": "Critical period plasticity in local cortical circuits",
            "authors": [
                {
                    "first": "T.K.",
                    "middle": [],
                    "last": "Hensch",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Rev Neurosci",
            "volume": "6",
            "issn": "",
            "pages": "877-888",
            "other_ids": {
                "DOI": [
                    "10.1038/nrn1787"
                ]
            }
        },
        "BIBREF2": {
            "title": "Consequences of perinatal cannabis exposure",
            "authors": [
                {
                    "first": "A.F.",
                    "middle": [],
                    "last": "Scheyer",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Melis",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Trezza",
                    "suffix": ""
                },
                {
                    "first": "O.J.J.",
                    "middle": [],
                    "last": "Manzoni",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Trends Neurosci",
            "volume": "42",
            "issn": "",
            "pages": "871-884",
            "other_ids": {
                "DOI": [
                    "10.1016/j.tins.2019.08.010"
                ]
            }
        },
        "BIBREF3": {
            "title": "Altering the course of schizophrenia: progress and perspectives",
            "authors": [
                {
                    "first": "M.J.",
                    "middle": [],
                    "last": "Millan",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Andrieux",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Bartzokis",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Cadenhead",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Dazzan",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Fusar-Poli",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Rev Drug Discov",
            "volume": "15",
            "issn": "",
            "pages": "485-515",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd.2016.28"
                ]
            }
        },
        "BIBREF4": {
            "title": "In utero marijuana exposure associated with abnormal amygdala dopamine D2\u00a0gene expression in the human fetus",
            "authors": [
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Dow-Edwards",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Anderson",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Minkoff",
                    "suffix": ""
                },
                {
                    "first": "Y.L.",
                    "middle": [],
                    "last": "Hurd",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Biol Psychiatry",
            "volume": "56",
            "issn": "",
            "pages": "909-915",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain",
            "authors": [
                {
                    "first": "C.-S.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "C.P.",
                    "middle": [],
                    "last": "Jew",
                    "suffix": ""
                },
                {
                    "first": "H.-C.",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Future Neurol",
            "volume": "6",
            "issn": "",
            "pages": "459-480",
            "other_ids": {
                "DOI": [
                    "10.2217/fnl.11.27"
                ]
            }
        },
        "BIBREF6": {
            "title": "Endocannabinoid functions controlling neuronal specification during brain development",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Harkany",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Keimpema",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Barab\u00e1s",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Mulder",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Mol Cell Endocrinol",
            "volume": "286",
            "issn": "",
            "pages": "S84-S90",
            "other_ids": {
                "DOI": [
                    "10.1016/j.mce.2008.02.011"
                ]
            }
        },
        "BIBREF7": {
            "title": "Early phytocannabinoid chemistry to endocannabinoids and beyond",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Mechoulam",
                    "suffix": ""
                },
                {
                    "first": "L.O.",
                    "middle": [],
                    "last": "Hanu\u0161",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Pertwee",
                    "suffix": ""
                },
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Howlett",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Nat Rev Neurosci",
            "volume": "15",
            "issn": "",
            "pages": "757-764",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Endocannabinoid signaling and synaptic function",
            "authors": [
                {
                    "first": "P.E.",
                    "middle": [],
                    "last": "Castillo",
                    "suffix": ""
                },
                {
                    "first": "T.J.",
                    "middle": [],
                    "last": "Younts",
                    "suffix": ""
                },
                {
                    "first": "A.E.",
                    "middle": [],
                    "last": "Ch\u00e1vez",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Hashimotodani",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Neuron",
            "volume": "76",
            "issn": "",
            "pages": "70-81",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Hardwiring the brain: endocannabinoids shape neuronal connectivity",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Berghuis",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Rajnicek",
                    "suffix": ""
                },
                {
                    "first": "Y.M.",
                    "middle": [],
                    "last": "Morozov",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Ross",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Mulder",
                    "suffix": ""
                },
                {
                    "first": "G.M.",
                    "middle": [],
                    "last": "Urb\u00e1n",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Science",
            "volume": "316",
            "issn": "",
            "pages": "1212-1216",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders",
            "authors": [
                {
                    "first": "M.-O.",
                    "middle": [],
                    "last": "Krebs",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Kebir",
                    "suffix": ""
                },
                {
                    "first": "T.M.",
                    "middle": [],
                    "last": "Jay",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Eur J Pain",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "The impact of exposure to cannabinoids in adolescence: insights from animal models",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Rubino",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Parolaro",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Biol Psychiatry",
            "volume": "79",
            "issn": "",
            "pages": "578-585",
            "other_ids": {
                "DOI": [
                    "10.1016/j.biopsych.2015.07.024"
                ]
            }
        },
        "BIBREF12": {
            "title": "The hippocampal\u2013prefrontal pathway: the weak link in psychiatric disorders?",
            "authors": [
                {
                    "first": "B.P.",
                    "middle": [],
                    "last": "Godsil",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Kiss",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Spedding",
                    "suffix": ""
                },
                {
                    "first": "T.M.",
                    "middle": [],
                    "last": "Jay",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur Neuropsychopharmacol",
            "volume": "23",
            "issn": "",
            "pages": "1165-1181",
            "other_ids": {
                "DOI": [
                    "10.1016/j.euroneuro.2012.10.018"
                ]
            }
        },
        "BIBREF13": {
            "title": "Keep off the grass? Cannabis, cognition and addiction",
            "authors": [
                {
                    "first": "H.V.",
                    "middle": [],
                    "last": "Curran",
                    "suffix": ""
                },
                {
                    "first": "T.P.",
                    "middle": [],
                    "last": "Freeman",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Mokrysz",
                    "suffix": ""
                },
                {
                    "first": "D.A.",
                    "middle": [],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "C.J.A.",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "L.H.",
                    "middle": [],
                    "last": "Parsons",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Rev Neurosci",
            "volume": "17",
            "issn": "",
            "pages": "293-306",
            "other_ids": {
                "DOI": [
                    "10.1038/nrn.2016.28"
                ]
            }
        },
        "BIBREF14": {
            "title": "Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Rubino",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Prini",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Piscitelli",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Zamberletti",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Trusel",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Melis",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Neurobiol Dis",
            "volume": "73",
            "issn": "",
            "pages": "60-69",
            "other_ids": {
                "DOI": [
                    "10.1016/j.nbd.2014.09.015"
                ]
            }
        },
        "BIBREF15": {
            "title": "Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Higuera-Matas",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Ucha",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Ambrosio",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Neurosci Biobehav Rev",
            "volume": "55",
            "issn": "",
            "pages": "119-146",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Cannabis and the developing brain: insights into its long-lasting effects",
            "authors": [
                {
                    "first": "Y.L.",
                    "middle": [],
                    "last": "Hurd",
                    "suffix": ""
                },
                {
                    "first": "O.J.",
                    "middle": [],
                    "last": "Manzoni",
                    "suffix": ""
                },
                {
                    "first": "M.V.",
                    "middle": [],
                    "last": "Pletnikov",
                    "suffix": ""
                },
                {
                    "first": "F.S.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Bhattacharyya",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Melis",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Neurosci",
            "volume": "39",
            "issn": "",
            "pages": "8250-8258",
            "other_ids": {
                "DOI": [
                    "10.1523/JNEUROSCI.1165-19.2019"
                ]
            }
        },
        "BIBREF17": {
            "title": "Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Frau",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Micz\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Traccis",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Aroni",
                    "suffix": ""
                },
                {
                    "first": "C.I.",
                    "middle": [],
                    "last": "Pongor",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Saba",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Nat Neurosci",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41593-019-0512-2"
                ]
            }
        },
        "BIBREF18": {
            "title": "Nanoscale structural plasticity of the active zone matrix modulates presynaptic function",
            "authors": [
                {
                    "first": "O.O.",
                    "middle": [],
                    "last": "Glebov",
                    "suffix": ""
                },
                {
                    "first": "R.E.",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Winterflood",
                    "suffix": ""
                },
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Owen",
                    "suffix": ""
                },
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "Barker",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Doherty",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Cell Rep",
            "volume": "18",
            "issn": "",
            "pages": "2715-2728",
            "other_ids": {
                "DOI": [
                    "10.1016/j.celrep.2017.02.064"
                ]
            }
        },
        "BIBREF19": {
            "title": "High times for cannabis: epigenetic imprint and its legacy on brain and behavior",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Szutorisz",
                    "suffix": ""
                },
                {
                    "first": "Y.L.",
                    "middle": [],
                    "last": "Hurd",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Neurosci Biobehav Rev",
            "volume": "85",
            "issn": "",
            "pages": "93-101",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neubiorev.2017.05.011"
                ]
            }
        },
        "BIBREF20": {
            "title": "Consequences of perinatal cannabis exposure",
            "authors": [
                {
                    "first": "A.F.",
                    "middle": [],
                    "last": "Scheyer",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Melis",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Trezza",
                    "suffix": ""
                },
                {
                    "first": "O.J.",
                    "middle": [],
                    "last": "Manzoni",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Trends Neurosci",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Prenatal cannabis exposure and infant outcomes: overview of studies",
            "authors": [
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Huizink",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Prog Neuropsychopharmacol Biol Psychiatry",
            "volume": "52",
            "issn": "",
            "pages": "45-52",
            "other_ids": {
                "DOI": [
                    "10.1016/j.pnpbp.2013.09.014"
                ]
            }
        },
        "BIBREF22": {
            "title": "Association of Prenatal Cannabis Exposure With Psychosis Proneness Among Children in the Adolescent Brain Cognitive Development (ABCD) Study",
            "authors": [
                {
                    "first": "J.D.",
                    "middle": [],
                    "last": "Fine",
                    "suffix": ""
                },
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "Moreau",
                    "suffix": ""
                },
                {
                    "first": "N.R.",
                    "middle": [],
                    "last": "Karcher",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Agrawal",
                    "suffix": ""
                },
                {
                    "first": "C.E.",
                    "middle": [],
                    "last": "Rogers",
                    "suffix": ""
                },
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Barch",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JAMA Psychiatry",
            "volume": "76",
            "issn": "",
            "pages": "762-764",
            "other_ids": {
                "DOI": [
                    "10.1001/jamapsychiatry.2019.0076"
                ]
            }
        },
        "BIBREF23": {
            "title": "Prenatal marijuana exposure impacts executive functioning into young adulthood: an fMRI study",
            "authors": [
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Mioduszewski",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Hatchard",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Byron-Alhassan",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Fall",
                    "suffix": ""
                },
                {
                    "first": "P.A.",
                    "middle": [],
                    "last": "Fried",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Neurotoxicol Teratol",
            "volume": "58",
            "issn": "",
            "pages": "53-59",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Prenatal marijuana exposure predicts marijuana use in young adulthood",
            "authors": [
                {
                    "first": "K.E.",
                    "middle": [],
                    "last": "Sonon",
                    "suffix": ""
                },
                {
                    "first": "G.A.",
                    "middle": [],
                    "last": "Richardson",
                    "suffix": ""
                },
                {
                    "first": "J.R.",
                    "middle": [],
                    "last": "Cornelius",
                    "suffix": ""
                },
                {
                    "first": "K.H.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "N.L.",
                    "middle": [],
                    "last": "Day",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Neurotoxicol Teratol",
            "volume": "47",
            "issn": "",
            "pages": "10-15",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "The neuropsychopharmacology of cannabis: a review of human imaging studies",
            "authors": [
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Bloomfield",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Hindocha",
                    "suffix": ""
                },
                {
                    "first": "S.F.",
                    "middle": [],
                    "last": "Green",
                    "suffix": ""
                },
                {
                    "first": "M.B.",
                    "middle": [],
                    "last": "Wall",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lees",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Petrilli",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Pharmacol Ther",
            "volume": "195",
            "issn": "",
            "pages": "132-161",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Perinatal exposure to environmental endocrine disruptors in the emergence of neurodevelopmental psychiatric diseases: a systematic review",
            "authors": [
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Rivollier",
                    "suffix": ""
                },
                {
                    "first": "M.-O.",
                    "middle": [],
                    "last": "Krebs",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Kebir",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Int J Environ Res Public Health",
            "volume": "16",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3390/ijerph16081318"
                ]
            }
        },
        "BIBREF27": {
            "title": "Long-term consequences of adolescent cannabinoid exposure in adult psychopathology",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Renard",
                    "suffix": ""
                },
                {
                    "first": "M.-O.",
                    "middle": [],
                    "last": "Krebs",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Le Pen",
                    "suffix": ""
                },
                {
                    "first": "T.M.",
                    "middle": [],
                    "last": "Jay",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Front Neurosci",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3389/fnins.2014.00361"
                ]
            }
        },
        "BIBREF28": {
            "title": "Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Renard",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Vitalis",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Rame",
                    "suffix": ""
                },
                {
                    "first": "M.-O.",
                    "middle": [],
                    "last": "Krebs",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Lenkei",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Le Pen",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Eur Neuropsychopharmacol",
            "volume": "26",
            "issn": "",
            "pages": "55-64",
            "other_ids": {
                "DOI": [
                    "10.1016/j.euroneuro.2015.11.005"
                ]
            }
        },
        "BIBREF29": {
            "title": "Adolescent exposure to \u0394 9 -tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons",
            "authors": [
                {
                    "first": "M.L.",
                    "middle": [],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Chadwick",
                    "suffix": ""
                },
                {
                    "first": "D.L.",
                    "middle": [],
                    "last": "Dickstein",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Purushothaman",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Egervari",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Rahman",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Mol Psychiatry",
            "volume": "24",
            "issn": "",
            "pages": "588-600",
            "other_ids": {
                "DOI": [
                    "10.1038/s41380-018-0243-x"
                ]
            }
        },
        "BIBREF30": {
            "title": "Adolescent \u03949-tetrahydrocannabinol exposure and astrocyte-specific genetic vulnerability converge on nuclear factor-\u03baB-cyclooxygenase-2\u00a0signaling to impair memory in adulthood",
            "authors": [
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Jouroukhin",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "A.V.",
                    "middle": [],
                    "last": "Shevelkin",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Hasegawa",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Abazyan",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Saito",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Biol Psychiatry",
            "volume": "85",
            "issn": "",
            "pages": "891-903",
            "other_ids": {
                "DOI": [
                    "10.1016/j.biopsych.2018.07.024"
                ]
            }
        },
        "BIBREF31": {
            "title": "Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders",
            "authors": [
                {
                    "first": "M.-O.",
                    "middle": [],
                    "last": "Krebs",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Kebir",
                    "suffix": ""
                },
                {
                    "first": "T.M.",
                    "middle": [],
                    "last": "Jay",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Eur J Pain Lond Engl",
            "volume": "23",
            "issn": "",
            "pages": "1225-1233",
            "other_ids": {
                "DOI": [
                    "10.1002/ejp.1377"
                ]
            }
        },
        "BIBREF32": {
            "title": "Acute and chronic effects of cannabinoids on human cognition\u00a0\u2013\u00a0a systematic review",
            "authors": [
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Broyd",
                    "suffix": ""
                },
                {
                    "first": "H.H.",
                    "middle": [],
                    "last": "van Hell",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Beale",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Y\u00fccel",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Solowij",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Biol Psychiatry",
            "volume": "79",
            "issn": "",
            "pages": "557-567",
            "other_ids": {
                "DOI": [
                    "10.1016/j.biopsych.2015.12.002"
                ]
            }
        },
        "BIBREF33": {
            "title": "Persistent cannabis users show neuropsychological decline from childhood to midlife",
            "authors": [
                {
                    "first": "M.H.",
                    "middle": [],
                    "last": "Meier",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Caspi",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Ambler",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Harrington",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Houts",
                    "suffix": ""
                },
                {
                    "first": "R.S.E.",
                    "middle": [],
                    "last": "Keefe",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "109",
            "issn": "",
            "pages": "E2657-E2664",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1206820109"
                ]
            }
        },
        "BIBREF34": {
            "title": "Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study",
            "authors": [
                {
                    "first": "M.H.",
                    "middle": [],
                    "last": "Meier",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Caspi",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Danese",
                    "suffix": ""
                },
                {
                    "first": "H.L.",
                    "middle": [],
                    "last": "Fisher",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Houts",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Arseneault",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Addict Abingdon Engl",
            "volume": "113",
            "issn": "",
            "pages": "257-265",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Cannabis-associated psychosis: neural substrate and clinical impact",
            "authors": [
                {
                    "first": "R.M.",
                    "middle": [],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Englund",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Abi-Dargham",
                    "suffix": ""
                },
                {
                    "first": "D.A.",
                    "middle": [],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Di Forti",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Davies",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Neuropharmacology",
            "volume": "124",
            "issn": "",
            "pages": "89-104",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neuropharm.2017.06.018"
                ]
            }
        },
        "BIBREF36": {
            "title": "Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Batalla",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Bhattacharyya",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Y\u00fccel",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Fusar-Poli",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Crippa",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Nogu\u00e9",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PloS One",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0055821"
                ]
            }
        },
        "BIBREF37": {
            "title": "The role of cannabinoids in neuroanatomic alterations in cannabis users",
            "authors": [
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Lorenzetti",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Solowij",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Y\u00fccel",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Biol Psychiatry",
            "volume": "79",
            "issn": "",
            "pages": "e17-e31",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Marijuana on the mind? The impact of marijuana on cognition, brain structure, and brain function, and related public policy implications",
            "authors": [
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Gruber",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Sagar",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Policy Insights Behav Brain Sci",
            "volume": "4",
            "issn": "",
            "pages": "104-111",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Cerebellar alterations in cannabis users: a systematic review",
            "authors": [
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Blithikioti",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Miquel",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Batalla",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Rubio",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Maffei",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Herreros",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Addict Biol",
            "volume": "24",
            "issn": "",
            "pages": "1121-1137",
            "other_ids": {
                "DOI": [
                    "10.1111/adb.12714"
                ]
            }
        },
        "BIBREF40": {
            "title": "Regular cannabis use is associated with altered activation of central executive and default mode networks even after prolonged abstinence in adolescent users: results from a complementary meta-analysis",
            "authors": [
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Blest-Hopley",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Giampietro",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Bhattacharyya",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Neurosci Biobehav Rev",
            "volume": "96",
            "issn": "",
            "pages": "45-55",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neubiorev.2018.10.026"
                ]
            }
        },
        "BIBREF41": {
            "title": "Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008\u00a0to 2016",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cerd\u00e1",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Mauro",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Hamilton",
                    "suffix": ""
                },
                {
                    "first": "N.S.",
                    "middle": [],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Santaella-Tenorio",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Hasin",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JAMA Psychiatry",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jamapsychiatry.2019.3254"
                ]
            }
        },
        "BIBREF42": {
            "title": "Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Arseneault",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cannon",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Poulton",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Caspi",
                    "suffix": ""
                },
                {
                    "first": "T.E.",
                    "middle": [],
                    "last": "Moffitt",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "BMJ",
            "volume": "325",
            "issn": "",
            "pages": "1212-1213",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Cannabis, schizophrenia and other non-affective psychoses: 35\u00a0years of follow-up of a population-based cohort",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Manrique-Garcia",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Zammit",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Dalman",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Hemmingsson",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Andreasson",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Allebeck",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Psychol Med",
            "volume": "42",
            "issn": "",
            "pages": "1321-1328",
            "other_ids": {
                "DOI": [
                    "10.1017/S0033291711002078"
                ]
            }
        },
        "BIBREF44": {
            "title": "Causal association between cannabis and psychosis: examination of the evidence",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Arseneault",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cannon",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Witton",
                    "suffix": ""
                },
                {
                    "first": "R.M.",
                    "middle": [],
                    "last": "Murray",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Br J Psychiatry",
            "volume": "184",
            "issn": "",
            "pages": "110-117",
            "other_ids": {
                "DOI": [
                    "10.1192/bjp.184.2.110"
                ]
            }
        },
        "BIBREF45": {
            "title": "Cannabis use and psychosis: a review of reviews",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Hasan",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "von Keller",
                    "suffix": ""
                },
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Friemel",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Hall",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Schneider",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Koethe",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Eur Arch Psychiatry Clin Neurosci",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s00406-019-01068-z"
                ]
            }
        },
        "BIBREF46": {
            "title": "US epidemiology of cannabis use and associated problems",
            "authors": [
                {
                    "first": "D.S.",
                    "middle": [],
                    "last": "Hasin",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Neuropsychopharmacol",
            "volume": "43",
            "issn": "",
            "pages": "195-212",
            "other_ids": {
                "DOI": [
                    "10.1038/npp.2017.198"
                ]
            }
        },
        "BIBREF47": {
            "title": "Can we make cannabis safer?",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Englund",
                    "suffix": ""
                },
                {
                    "first": "T.P.",
                    "middle": [],
                    "last": "Freeman",
                    "suffix": ""
                },
                {
                    "first": "R.M.",
                    "middle": [],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "McGuire",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Lancet Psychiatry",
            "volume": "4",
            "issn": "",
            "pages": "643-648",
            "other_ids": {
                "DOI": [
                    "10.1016/S2215-0366(17)30075-5"
                ]
            }
        },
        "BIBREF48": {
            "title": "How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review",
            "authors": [
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Freeman",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Petrilli",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lees",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Hindocha",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Mokrysz",
                    "suffix": ""
                },
                {
                    "first": "H.V.",
                    "middle": [],
                    "last": "Curran",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Neurosci Biobehav Rev",
            "volume": "107",
            "issn": "",
            "pages": "696-712",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neubiorev.2019.09.036"
                ]
            }
        },
        "BIBREF49": {
            "title": "Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Black",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Stockings",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Campbell",
                    "suffix": ""
                },
                {
                    "first": "L.T.",
                    "middle": [],
                    "last": "Tran",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Zagic",
                    "suffix": ""
                },
                {
                    "first": "W.D.",
                    "middle": [],
                    "last": "Hall",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Lancet Psychiatry",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S2215-0366(19)30401-8"
                ]
            }
        },
        "BIBREF50": {
            "title": "Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "McGuire",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Robson",
                    "suffix": ""
                },
                {
                    "first": "W.J.",
                    "middle": [],
                    "last": "Cubala",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Vasile",
                    "suffix": ""
                },
                {
                    "first": "P.D.",
                    "middle": [],
                    "last": "Morrison",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Barron",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Am J Psychiatry",
            "volume": "175",
            "issn": "",
            "pages": "225-231",
            "other_ids": {
                "DOI": [
                    "10.1176/appi.ajp.2017.17030325"
                ]
            }
        },
        "BIBREF51": {
            "title": "The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial",
            "authors": [
                {
                    "first": "D.L.",
                    "middle": [],
                    "last": "Boggs",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Surti",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Niciu",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Pittman",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Psychopharmacology (Berl)",
            "volume": "235",
            "issn": "",
            "pages": "1923-1932",
            "other_ids": {
                "DOI": [
                    "10.1007/s00213-018-4885-9"
                ]
            }
        },
        "BIBREF52": {
            "title": "Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia",
            "authors": [
                {
                    "first": "F.F.",
                    "middle": [],
                    "last": "Peres",
                    "suffix": ""
                },
                {
                    "first": "M.C.",
                    "middle": [],
                    "last": "Diana",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Levin",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Suiama",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Almeida",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Vendramini",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Front Pharmacol",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3389/fphar.2018.00901"
                ]
            }
        },
        "BIBREF53": {
            "title": "Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Stark",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Ruda-Kucerova",
                    "suffix": ""
                },
                {
                    "first": "F.A.",
                    "middle": [],
                    "last": "Iannotti",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "D\u2019Addario",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Di Marco",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Pekarik",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Neuropharmacology",
            "volume": "146",
            "issn": "",
            "pages": "212-221",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neuropharm.2018.11.035"
                ]
            }
        },
        "BIBREF54": {
            "title": "Chronic adolescent \u03949-tetrahydrocannabinol treatment of male mice leads to long-term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Murphy",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Mills",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Winstone",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Leishman",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Wager-Miller",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Bradshaw",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Cannabis Cannabinoid Res",
            "volume": "2",
            "issn": "",
            "pages": "235-246",
            "other_ids": {
                "DOI": [
                    "10.1089/can.2017.0034"
                ]
            }
        },
        "BIBREF55": {
            "title": "Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders",
            "authors": [
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "Osborne",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Solowij",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Babic",
                    "suffix": ""
                },
                {
                    "first": "J.S.",
                    "middle": [],
                    "last": "Lum",
                    "suffix": ""
                },
                {
                    "first": "X.-F.",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Newell",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Brain Behav Immun",
            "volume": "81",
            "issn": "",
            "pages": "574-587",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bbi.2019.07.018"
                ]
            }
        }
    }
}